Glaucoma: changing concepts and future directions

Mayo Clinic Proceedings

Volumn 71, Issue 7, 1996, Pages 689-694

  Liesegang, Thomas J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; MIOTIC AGENT; PROSTAGLANDIN;

AGE; ANOREXIA; CARDIOTOXICITY; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; CONGENITAL GLAUCOMA; DEPRESSION; DISEASE CLASSIFICATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; FAMILY HISTORY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LASER SURGERY; MALAISE; MIOSIS; NEGRO; OPEN ANGLE GLAUCOMA; OPTIC NERVE DISEASE; PHYSICIAN; PRIMARY GLAUCOMA; PRIMARY MEDICAL CARE; REVIEW; RISK FACTOR; SECONDARY GLAUCOMA; TRABECULOPLASTY; UNITED STATES;

EID: 0030317108     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)63007-3     Document Type: Article

References (14)

1. Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol 1983; 118:166-191
2. Fechtner RD, Weinreb RN. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol 1994; 39:23-42
3. American Academy of Ophthalmology Quality of Care Committee Glaucoma Panel. Preferred Practice Patterns: Primary Open-Angle Glaucoma. San Francisco: American Academy of Ophthalmology, 1992
4. Sommer A, Tielsch JM, Katz J, Quigley HA, Gotisch JD, Javitt J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Study. Arch Ophthalmol 1991; 109:1090-1095
5. Shields MB. The challenge of screening for glaucoma [editorial]. Am J Ophthalmol 1995; 120:793-795
6. Sommer A. Intraocular pressure and glaucoma. Am J Ophthalmol 1989; 107:186-188
7. Tielsch JM, Katz J, Singh K, Quigley HA, Gottsch JD, Javitt J, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol 1991; 134:1102-1110
8. Le Blanc R. Value of intraocular pressure measurement as a screening tool for glaucoma. Surv Ophthalmol 1989; 33(Suppl):445-446
9. Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 1994; 101:1651-1656
10. Diggory P, Franks W. Medical treatment of glaucoma-a reappraisal of the risks. Br J Ophthalmol 1996; 80:85-89
11. Sherwood MB, Grierson I, Miller L, Hitchings RA. Longterm morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology 1989; 96:327-335
12. Lichter PR. Genetic clues to glaucoma's secrets: the L. Edward Jackson Memorial Lecture; part 2. Am J Ophthalmol 1994; 117:706-727
13. Van Buskirk EM, Cioffi GA. Glaucomatous optic neuropathy. Am J Ophthalmol 1992; 113:447-452
14. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow-Up Study. 7. Results. Am J Ophthalmol 1995; 120:718-731